Clinical Trial Update: Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients [Phase 2]

View source ↗

Summary

This clinical trials update reports the extension of the AOC 1001-CS1 (MARINA) study in adults with myotonic dystrophy type 1 (DM1). The Phase 2 trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• AOC 1001-CS1 (MARINA)

Snippet

Sponsor: Avidity Biosciences, Inc. | Conditions: DM1, Muscular Dystrophies | Phase 2 | Status: COMPLETED